National Health Investors (NHI) Projected to Post Earnings on Wednesday

National Health Investors (NYSE:NHI - Get Free Report) is anticipated to issue its Q2 2025 quarterly earnings data after the market closes on Wednesday, August 6th. Analysts expect the company to announce earnings of $1.17 per share and revenue of $86.46 million for the quarter. National Health Investors has set its FY 2025 guidance at 4.680-4.730 EPS.

National Health Investors (NYSE:NHI - Get Free Report) last posted its quarterly earnings results on Monday, May 5th. The real estate investment trust reported $1.15 earnings per share for the quarter, topping analysts' consensus estimates of $1.13 by $0.02. National Health Investors had a net margin of 41.15% and a return on equity of 10.64%. The business had revenue of $68.87 million during the quarter, compared to the consensus estimate of $85.13 million. During the same period in the previous year, the firm posted $1.10 earnings per share. National Health Investors's revenue for the quarter was up 9.6% compared to the same quarter last year. On average, analysts expect National Health Investors to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

National Health Investors Trading Up 2.1%

NYSE:NHI traded up $1.44 during trading hours on Friday, hitting $71.30. The stock had a trading volume of 283,131 shares, compared to its average volume of 226,509. National Health Investors has a one year low of $65.13 and a one year high of $86.13. The company has a debt-to-equity ratio of 0.88, a quick ratio of 16.55 and a current ratio of 16.55. The company has a market cap of $3.33 billion, a price-to-earnings ratio of 22.63, a P/E/G ratio of 3.52 and a beta of 0.73. The business's 50 day moving average is $71.16 and its 200-day moving average is $71.90.

National Health Investors Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 1st. Stockholders of record on Monday, June 30th were given a dividend of $0.90 per share. The ex-dividend date of this dividend was Monday, June 30th. This represents a $3.60 annualized dividend and a dividend yield of 5.0%. National Health Investors's dividend payout ratio is currently 114.29%.

Institutional Investors Weigh In On National Health Investors

Institutional investors have recently added to or reduced their stakes in the business. Jane Street Group LLC increased its position in shares of National Health Investors by 1,728.4% in the first quarter. Jane Street Group LLC now owns 69,697 shares of the real estate investment trust's stock worth $5,148,000 after purchasing an additional 65,885 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of National Health Investors by 9.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 249,937 shares of the real estate investment trust's stock worth $18,460,000 after purchasing an additional 21,851 shares during the last quarter. Finally, NewEdge Advisors LLC increased its position in shares of National Health Investors by 28.7% in the first quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust's stock worth $114,000 after purchasing an additional 345 shares during the last quarter. 62.51% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have commented on the stock. KeyCorp upgraded shares of National Health Investors from a "sector weight" rating to an "overweight" rating and set a $80.00 price target for the company in a research note on Thursday, July 10th. Wedbush upgraded shares of National Health Investors to a "strong-buy" rating in a report on Wednesday, July 2nd. Finally, Truist Financial upgraded shares of National Health Investors from a "hold" rating to a "buy" rating and set a $77.00 target price for the company in a research note on Wednesday, July 2nd. Two equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $84.60.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.